The Amyloidosis Foundation is dedicated to improving the diagnosis and treatment of amyloidosis, a rare and often misdiagnosed disease caused by the deposition of amyloid proteins in various organs. The foundation focuses on increasing awareness, providing patient resources, funding research, and supporting medical education to advance the understanding and management of amyloidosis.
2003
20-0291856
$1.056 million
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Information on AL amyloidosis including symptoms, diagnosis, and treatment options.
Stay informed about our events, including webinars and conferences.
Real stories from patients affected by amyloidosis, showcasing their journeys.
Research Grants
Annual grants for junior research scientists working on amyloidosis.
Established Treatment Options
Support for the development of several drugs approved for treating ATTR amyloidosis.
Patient Education Programs
Hosted multiple webinars and informational sessions tailored to educate patients and caregivers.
2024-10-15
Webinar on Emerging Treatment Options for Amyloidosis
2024-06-30
Patient gathering to discuss experiences and resources.
2024-05-17
Conference focused on new research breakthroughs.
2024-11-20
Join us for an informative session on managing neuropathy related to amyloidosis.
Learn More2024-12-04
A reflective session on coping strategies for patients and families.
Learn MoreProvides funding to researchers focusing on amyloidosis to foster innovative treatments.
Learn MoreEducational materials and webinars designed to empower patients and families.
Learn MoreInitiatives to raise public awareness about amyloidosis and its effects.
Learn MoreAssist in the organization and execution of foundation events.
Connect with patients to provide support and information.
"There is no greater reminder that we should cherish moments than nearly dying. My experience with amyloidosis taught me the importance of hope and resilience."
Lou Catania
"Being involved with the Amyloidosis Foundation has allowed me to make a difference in the lives of so many patients and their families."
Patient Advocate
Volunteer
"The support from the Amyloidosis Foundation has been instrumental in advancing critical research that can lead to life-saving treatments."
Researcher Partner
Research Collaborator
Overall Score
63
54
/100
Program Expense Ratio
84.37%
16
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.02026
20
/20
Working Capital Ratio
1.73
14
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 606.8K | 85.41% |
Program Services | 0 | 0.00% |
Investment Income | 14.42K | 2.03% |
Sales of Non-Inventory Assets | -5.583K | -0.79% |
Other Notable Sources | 0 | 0.00% |
Total Revenue | 710.4K | 100.00% |
Med Research
Down Syndrome ResearchMed Research
Down Syndrome ResearchMed Research
Down Syndrome ResearchMed Research
Down Syndrome ResearchMed Research
Down Syndrome Research